TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005
TCL Archive Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11 March 29, 1974
